450 related articles for article (PubMed ID: 477314)
21. Epidemiology of endometriosis in women attending family planning clinics.
Vessey MP; Villard-Mackintosh L; Painter R
BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
[TBL] [Abstract][Full Text] [Related]
22. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract][Full Text] [Related]
23. Iron status in Danish women aged 35-65 years. Relation to menstruation and method of contraception.
Milman N; Rosdahl N; Lyhne N; Jørgensen T; Graudal N
Acta Obstet Gynecol Scand; 1993 Nov; 72(8):601-5. PubMed ID: 8259744
[TBL] [Abstract][Full Text] [Related]
24. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.
Milman N; Clausen J; Byg KE
Ann Hematol; 1998; 77(1-2):13-9. PubMed ID: 9760147
[TBL] [Abstract][Full Text] [Related]
25. Acceptability study of the two versus three monthly injectable contraceptives.
Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
[TBL] [Abstract][Full Text] [Related]
26. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Nilsson CG; Allonen H; Diaz J; Luukkainen T
Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
[TBL] [Abstract][Full Text] [Related]
27. A longitudinal study of contraception and pregnancy outcome in a representative sample of young Swedish women.
Milsom I; Sundell G; Andersch B
Contraception; 1991 Feb; 43(2):111-9. PubMed ID: 2040167
[TBL] [Abstract][Full Text] [Related]
28. Use-effectiveness of oral and intrauterine contraception.
Tietze C; Lewitt S
Fertil Steril; 1971 Aug; 22(8):508-13. PubMed ID: 5110233
[TBL] [Abstract][Full Text] [Related]
29. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status.
Larsson G; Milsom I; Lindstedt G; Rybo G
Contraception; 1992 Oct; 46(4):327-34. PubMed ID: 1486771
[TBL] [Abstract][Full Text] [Related]
30. Menstrual flow duration and spotting following Multiload Copper 250 intra-uterine device insertion.
Goh TH; Ang ES; Yip YC
J Obstet Gynaecol (Lahore); 1983 Oct; 4(2):127-8. PubMed ID: 12279948
[TBL] [Abstract][Full Text] [Related]
31. Menstrual blood loss of TCu-380 A and TCu-200 B IUDs.
El-sheikha Z; Hamza A; Mahmoud M
Popul Sci; 1990 Jul; ():55-62. PubMed ID: 12343358
[TBL] [Abstract][Full Text] [Related]
32. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
[TBL] [Abstract][Full Text] [Related]
33. Menstrual blood loss during oral contraceptive therapy and in IUD users.
Hefnawi F; Younis N; Zaki K; Rassik SA; Mekkawi T
Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):1-4. PubMed ID: 12254505
[TBL] [Abstract][Full Text] [Related]
34. Contraception after thirty-five.
Luukkainen T
Acta Obstet Gynecol Scand; 1992 Apr; 71(3):169-74. PubMed ID: 1317637
[TBL] [Abstract][Full Text] [Related]
35. Intrauterine contraceptive devices. Complications associated with their use.
Nagel TC
Postgrad Med; 1983 Mar; 73(3):155-64. PubMed ID: 6828391
[TBL] [Abstract][Full Text] [Related]
36. The menstrual cycle in women using an intrauterine device.
Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
[TBL] [Abstract][Full Text] [Related]
38. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
Umapathysivam K; Jones WR
Contraception; 1980 Oct; 22(4):425-40. PubMed ID: 6160951
[TBL] [Abstract][Full Text] [Related]
39. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
40. Comparison of three different models of the copper T intrauterine contraceptive device.
Roy S; Casagrande J; Cooper DL; Mishell DR
Am J Obstet Gynecol; 1979 Jul; 134(5):568-74. PubMed ID: 453297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
